Cardiovascular Research Research on cardiovascular biomarkers, lipid profiles, and blood pressure trajectories
Cost and insurance considerations Tirzepatide as Zepbound runs about CAD 600 to 700 a month at retail in Canada and the U.S
Injectable therapy is easier to manage when refill planning happens before the last scheduled dose
Regain was observed across subgroups, with significant regain at 12 weeks in trials of GLP-1s
The two agents differ in their mechanisms of action: Resmetirom is a THR- agonist, while Semaglutide is a GLP-1 receptor agonist
From debunking the Thanksgiving turkey makes you sleepy myth to explaining how creatine, red light, and sunlight impact brain function, sleep, and recovery, this episode dives deep into the biochemistry behind how the body actually works